WebJul 30, 2015 · Remission rates for newly diagnosed adult patients with acute lymphoblastic lymphoma (ALL) are >80% with standard induction regimens. 1-5 It is unfortunate that a subset of patients will be refractory to initial therapy and that an additional 30% to 60% of patients will relapse despite aggressive consolidation and maintenance chemotherapy … WebAug 1, 2024 · The treatment of older patients with newly diagnosed acute myeloid leukemia (AML) using intensive chemotherapy is associated with treatment intolerance and poor survival. We evaluated two new lower-intensity regimens with clofarabine (n = 119) or …
Clofarabine and cytarabine combination as induction therapy for …
Webclofarabine (Rx) Brand and Other Names: Clolar Classes: Antineoplastics, Antimetabolite Dosing & Uses AdultPediatric Dosage Forms & Strengths injectable solution 1mg/mL (20mg vial) Refractory or... WebDec 2, 2016 · clofarabine, cytarabine, decitabine, idarubicin, leukemia, myelocytic, acute, allopurinol, chemotherapy regimen, c-reactive protein, cyclic amp receptor protein, epley maneuver Author notes * Asterisk with author names denotes non-ASH members. © 2016 by The American Society of Hematology Volume 128, Issue 22 December 2 2016 … highest rated winter jackets
Antineoplastics SpringerLink
WebFeb 21, 2013 · Clofarabine is a chemotherapy drug that has been used in the treatment of leukemia in children and adults. Information from other research studies suggests that this drug may also be effective in patients with LCH. WebThe reported PETHEMA experience shows that clofarabine-based chemo-therapy regimens can induce CR in a proportion of ALL and LL patients, allowing them to received further therapies (such as allo-HCT) leading to long-term remissions. In heavily … WebVinblastine chemotherapy in adult patients with langerhans cell histiocytosis: a multicenter retrospective study [J]. Orphanet J Rare Dis, 2024, 12 (1): 95. ... Clofarabine salvage therapy in refractory multifocal histiocytic disorders, including Langerhans cell histiocytosis, juvenile xanthogranuloma and Rosai-Dorfman disease [J]. how have you been affected or effected